Hello, everyone. Welcome to today's session. Thank you so much for joining us today. Before we begin, I'd like to cover a few quick notes with you about our webinar platform. Today's webinar will be ...
BOULDER, Colo., Nov. 3, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results